Concepedia
Statistics
Publications
16
Citations
1K
H-Index
14
Active since
1985
Affiliations
Children's Hospital of Michigan(Current)
Wayne State University
The Barbara Ann Karmanos Cancer Institute
Duquesne University
Mayo Clinic
Mark Stout is an author at Children's Hospital of Michigan specializing in pharmacology, oncology, and medicine.
Publications per year
1985–2013
Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin.
Jeffrey W. Taub, Xi Huang, Larry H. Matherly et al. · PubMed · 1999 · 183 citations
Life Sciences, Genetics, Molecular Biology +15
GATA1, Cytidine Deaminase, and the High Cure Rate of Down Syndrome Children With Acute Megakaryocytic Leukemia
Yubin Ge, Mark Stout, Dana Tatman et al. · JNCI Journal of the National Cancer Institute · 2005 · 118 citations · Full text
Medicine, Molecular Biology, Oncology +15
Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia
Yubin Ge, Alan A. Dombkowski, Katherine M. LaFiura et al. · Blood · 2005 · 107 citations · Full text
Life Sciences, Molecular Biology, Molecular Genetics +14
Melatonin cytotoxicity in human leukemia cells: relation with its pro‐oxidant effect
Mustafa Büyükavcı, Öner Özdemır, Steven Buck et al. · Fundamental and Clinical Pharmacology · 2006 · 99 citations
Life Sciences, Oncology, Pharmacology +13
The Role of Cytidine Deaminase and GATA1 Mutations in the Increased Cytosine Arabinoside Sensitivity of Down Syndrome Myeloblasts and Leukemia Cell Lines
Yubin Ge, Tanya L. Jensen, Mark Stout et al. · Cancer Research · 2004 · 81 citations
Life Sciences, Hematology, Molecular Biology +14
1–5 of 16